AzTrials
AzTrials

StrokeNCT06230718

EMG Analysis in ABI: Motor Imagery and Action

A study testing Motor Imagery (MI) and Action Observation (AO) in people with Stroke and Quality of Life, run by University of Salamanca at 1 site in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study focuses on electromyographic analysis of upper limb muscle activation in stroke survivors during Motor Imagery (MI) and Action Observation (AO) rehabilitation techniques. Read more about this study

Who is it for?
Ages 18 to 99 years
Conditions the study is for
Stroke, Quality of Life, Mirror Movement
What is being tested?
Motor Imagery (MI) and Action Observation (AO)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
28 participants
Where
1 siteSpain
Study dates
1 Jan 2024to 30 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Being over 18 years of age
  • Diagnoses of established stroke
  • Present limitations or motor response deficiencies in the upper limb
  • Maintain cognitive functions with the ability to follow the instructions of the interventions and evaluations (MOCA>14)

Who cannot join

  • Diagnosed with mental illness before the stroke
  • Other systemic conditions on the central nervous system
  • Cardiorespiratory system pathologies in severe cases
  • Acute period, fever, muscle inflammation or myopathies
  • Any type of vascular and organic insufficiency
  • Liver disease or skin lesions in the area of application of the electrodes.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Beatriz María Bermejo Gil, Dr contact

622289468

beatriz.bermejo@usal.es

Ana MAría Martín Nogueras, Dr contact

677510296

anamar@usal.es

Spain1 site, 1 recruiting
  • Universidad de Salmanca

    Salamanca, Salamanca, 37007

    Beatriz María Bermejo Gil, Dr., 622289468, beatriz.bermejo@usal.es

    Ana María Martín Nogueras, 677510296, anamar@usal.es

    Recruiting

Other trials in Spain

About this study

Official title: Upper Limb Electromyographic Response to Motor Imagery and Action Observation in Acquired Brain Injury Patients.

This study focuses on electromyographic analysis of upper limb muscle activation in stroke survivors during Motor Imagery (MI) and Action Observation (AO) rehabilitation techniques. By measuring muscle activity in the wrist and finger flexors and extensors, the research seeks to understand the impact of MI and AO on motor function recovery post-stroke. Conducted at the University of Salamanca, the study involves stroke survivors participating in a series of three experimental sessions. The analysis will correlate electromyographic responses with functional independence, limb functionality, and cognitive factors. The research aims to contribute to the fields of occupational therapy and physiotherapy, offering insights into effective rehabilitation methods for improving quality of life in stroke survivors.

Read the detailed description

This study investigates muscle activation in the upper limbs of stroke survivors using electromyographic analysis during Motor Imagery (MI) and Action Observation (AO). Stroke, a major cause of disability, often results in motor impairments in the upper limb, impacting daily activities. The research focuses on innovative rehabilitation techniques based on neuroplasticity, such as MI and AO, stimulated by the discovery of mirror neurons.

The primary goal is to record upper limb muscle activation during MI and AO, using surface electromyography to measure activation in wrist and finger flexors and extensors. The study will also explore the relationship between electromyographic responses and factors like daily activity independence, limb functionality, quality of life, mental evocation ability, and cognitive impairment.

Conducted at the University of Salamanca, the study will recruit stroke survivors for a three-session experimental protocol involving control, MI, and AO conditions. Data will be analyzed with SPSS Statistics, ensuring anonymity and ethical compliance. The research aims to enhance understanding of effective neurorehabilitation techniques, contributing to the fields of occupational therapy and physiotherapy.

Being tested
Motor Imagery (MI), Action Observation (AO), Control condition- placebo
Keywords
Stroke rehabilitation, Electromyography, Neuroplasticity, Upper Linb, Neurorehabilitation
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motor Imagery (MI)Other

    mental process where an individual visualizes or imagines themselves performing a movement without actually executing it physically. This cognitive process involves the mental rehearsal of motor actions, engaging similar neural pathways that are used when physically performing the action.

  • Action Observation (AO)Other

    rehabilitation technique based on the principle of observing actions to improve motor function and learning. This approach is rooted in the concept of the mirror neuron system, a group of neurons that are activated both when a person performs an action and when they observe the same action performed by others.

  • Control condition- placeboOther

    Recording with images of landscapes without the presence of any person or animal that could evoke MI or OA.

Study groups in NCT06230718
Study groupRoleWhat they receive
Intervention groupExperimentalThe intervention group will receive 3 experimental procedures 1. Placebo control 2. Motor Imagery- Active Comparator 3. Action Observation (OA) Active comparator muscle activation control by surface electromyography will be recorded in these three situations
Receives: Other: Motor Imagery (MI); Other: Action Observation (AO); Other: Control condition- placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Disability and Dependence Level - Barthel Index

    A general measure assessing patient independence, evaluating performance in basic daily activities (ADLs).

    Measured: Administered once, typically taking a few minutes.

  2. Upper Limb Functionality - Action Research Arm Test (ARAT)

    Assesses upper limb functionality post-cortical injury, involving manipulation tasks with various objects.

    Measured: Administration time ranges from 5 to 15 minutes.

  3. Cognitive Impairment - Montreal Cognitive Assessment (MoCA)

    Evaluates mild cognitive dysfunctions across multiple domains, including attention, memory, language, and executive functions.

    Measured: takes about 10 minutes for administration.

  4. Perception Impairment - Loewenstein Occupational Therapy Cognitive Assessment (LOTCA)

    Specific for occupational therapy in stroke patients, assessing visual, spatial, motor, and cognitive perception.

    Measured: Duration varies based on the number and type of subtests administered.

  5. Mental Evocation Ability - Mental Evocation of Images, Movements, and Activities Questionnaire (CEMIMA)

    Measures the ability to mentally form visual and kinesthetic images of the hand/upper limb.

    Measured: Duration varies

  6. Quality of Life Perception - Stroke Impact Scale 16 (SIS-16)

    A self-report measure focusing on physical aspects including strength, hand function, mobility, and ADLs.

    Measured: 5-10 minutes.

  7. Electromyographic Activity During MI and AO

    muscle activity using surface electrodes on wrist extensors and flexors.

    Measured: during the experimental setup

Secondary outcomes (9)
  1. Age

    birth age

    Measured: 1 minute

  2. gender

    he gender with which the participant identifies

    Measured: 1 minute

  3. Marital Status

    single, married, divorced

    Measured: 1 minute

  4. Education Level

    he highest level of education

    Measured: 1 minute

  5. Economic Status

    participant's economic

    Measured: 1 minute

  6. Affected Side

    The side of the body affected by the stroke or injury

    Measured: 1 minute

  7. Dominant Side

    The side of the body that is the participant's natural dominant side

    Measured: 1 minute

  8. Type of Lesion

    specific type of brain injury

    Measured: 1 minute

  9. Time Since Injury

    time since the participant had the brain injury or stroke.

    Measured: 1 minute

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2024
  2. Study start1 Jan 2024
  3. Primary completion30 Jan 2026 (estimated)
  4. Study completion30 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
28 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06230718
Sponsor's protocol ID
MIAO
Status last verified
Oct 2025
First submitted
19 Jan 2024
Last updated
7 Oct 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Motor Imagery (MI) and Action Observation (AO) in people with Stroke and Quality of Life, run by University of Salamanca at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Beatriz María Bermejo Gil, Dr (622289468, beatriz.bermejo@usal.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Disability and Dependence Level - Barthel Index (time frame: Administered once, typically taking a few minutes.). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in